New topics for implementation within the Dutch “Care Evaluation and Appropriate Use” program

The Care Evaluation and Appropriate Use program (Zorgevaluatie en Gepast Gebruik, ZE&GG) aims to implement appropriate care by evaluating and implementing knowledge about what constitutes appropriate care. The results of care evaluations within the program will change medical practice. The Program is a joint initiative of all parties involved in medical specialist care, with the Dutch Organization for Health Research and Development (ZonMw) and the Dutch Healthcare Institute (ZIN) as strategic partners.

The Implementation Agenda contains topics on what constitutes proven best care and which should be implemented in daily healthcare practice. Only topics that meet certain quality and effectiveness requirements are eligible for inclusion in the Implementation Agenda. After the topics are included in the Implementation Agenda, all healthcare providers must demonstrate the implementation results within two years. 

On January 29, 2026, nine new topics were added to the Implementation Agenda, concerning the in-vitro diagnostic, gastrointestinal, and ENT fields. Some examples are provided below:

• Rhinoplasty for nasal airway obstruction;
• Recommendation not to routinely perform a complementary oncological resection after local excision of a pT1-2 colon carcinoma;
• Whole genome sequencing (WGS) in the diagnosis of NTRK gene fusions in patients with solid tumors;
• Tumor agnostic: Test specific targets to determine optimal therapy for solid tumor types using the list of Clinically Necessary Targets.

In addition, 16 topics were removed from the agenda: 13 have been sufficiently implemented, and three were no longer relevant.

See the full details in Dutch here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.